HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An open multicenter study of the efficacy of MDL 72,974A, a monoamine oxidase type B (MAO-B) inhibitor, in Parkinson's disease.

AuthorsV V Myllylä, K A Sotaniemi, J Aasly, O Sjaastad, U Rinne, T McIntyre, G Cremer
JournalAdvances in neurology (Adv Neurol) Vol. 60 Pg. 676-80 ( 1993) ISSN: 0091-3952 [Print] United States
PMID8420209 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)
Chemical References
  • Allyl Compounds
  • Butylamines
  • Monoamine Oxidase Inhibitors
  • mofegiline
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Allyl Compounds
  • Butylamines (adverse effects, therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors (adverse effects, therapeutic use)
  • Motor Activity (drug effects)
  • Neurologic Examination (drug effects)
  • Parkinson Disease (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: